title: COX-2 in cancer--a player that's defining the rules.
authors.forename: Ernest T
authors.initials: ET
authors.lastname: Hawk
authors.forename: Jaye L
authors.initials: JL
authors.lastname: Viner
authors.forename: Andrew
authors.initials: A
authors.lastname: Dannenberg
authors.forename: Raymond N
authors.initials: RN
authors.lastname: DuBois
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis; D000068579:Celecoxib; D002455:Cell Division; D051546:Cyclooxygenase 2; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism* / Q000502:physiology*; D008565:Membrane Proteins; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000517:prevention & control; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism* / Q000502:physiology*; D011720:Pyrazoles; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D007527:Isoenzymes; D008565:Membrane Proteins; D011720:Pyrazoles; D013449:Sulfonamides; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D000068579:Celecoxib